Your clinician customized this product information just for you
Product Image

Integra® PriMatrix® Dermal Repair Scaffold, Per Square Centimeter

PriMatrix® Dermal Repair Scaffold is an acellular matrix.

INTENDED USES: For the management of wounds that include: Partial and full thickness wounds, pressure, diabetic, and venous ulcers, second-degree burns, surgical wounds—donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence, trauma wounds —abrasions, lacerations, and skin tears, tunneled/undermined wounds and raining wounds

CLAIMED FEATURES: It is derived from fetal bovine dermis, this acellular dermal matrix provides an ideal environment to support cellular repopulation and revascularization processes critical in wound healing. PriMatrix is particularly rich in Type III collagen, a collagen found in fetal dermis that is active in developing and healing tissues. PriMatrix is an acellular dermal tissue matrix derived from fetal bovine dermis. The device is supplied sterile in a variety of sizes to be trimmed by the surgeon to meet the individual patient’s needs.

OPTIONS: Per Square Centimeter

607-001-009: 0.2x26.5 cm

607-001-440: 4x4 cm Solid

607-001-660: 6x46 cm Solid

607-001-440: 4x4 cm Fenestrated

607-004-660: 6x6 cm Fenestrated

607-005-014: 14mm Meshed Disc

607-005-018: 18mm Meshed Disc

607-005-220: 2x2 cm Meshed

607-005-330: 3x3 cm Meshed

607-005-440: 4x4 cm Meshed

607-005-550: 5x5 cm Meshed

607-005-660: 6x6 cm Meshed

Product Information

The addition of Skin Substitutes or Cellular or Tissue Based Products (CTPs) to certain wounds may afford a healing advantage over dressings and conservative treatments when these options appear insufficient to affect complete healing, after at least a 30 day period of comprehensive conservative therapy. There are currently a wide variety of bioengineered products available for soft tissue coverage to affect closure. • Human skin allografts are derived from donated human skin (cadavers) • Allogeneic matrices are derived from human tissue (fibroblasts or membrane) • Composite matrices are derived from human keratinocytes, fibroblasts and xenogeneic collagen • Acellular matrices are derived from allogeneic (non-related human donors) or xenogeneic (other species) collagen, membrane, or cellular remnants

Pricing and Suppliers

Is it covered by Medicare Part B?

Medicare covers the application of Cellular and Tissue Based Products (CTPs) for chronic Wounds, which are defined as wounds that do not respond to standard wound treatment for at least a 30 day period during organized comprehensive conservative therapy. Medicare has guidelines that establish what is considered medically necessary and how often an item can be used.

How can I purchase this product?

For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.

The table below shows highest and lowest Medicare pricing across the country
DescriptionMedicare DME co-payment Min / Max
Primatrix, per square centimeter $0.00 / $0.00
Estimated out-of-pocket cost:

If your insurance does not cover this product, you can purchase it directly from any store. A list of online stores and prices is provided below for your convenience. For updated prices, find it on the internet at https://woundreference.com/app/product?id=678

Other Stores

* Indicates whether store accepts Medicare or commercial insurance, but may not apply to this specific product. See coding, coverage and reimubursement for more information.
The information on this handout is for your convenience and educational purposes only. All product claims and specifications are those of the product suppliers. It does not constitute medical advice or a guarantee for reimbursement. Prices may have changed and suppliers may not have product in stock. Please confirm accuracy and appropriateness of information with insurance carrier and product supplier. Clinician and WoundReference assume no liability for inaccuracies or misstatements about products and insurance coverage.